National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,745 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1291 out of 2,175

Result pages: prev   1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300   next


VAERS ID: 1260514 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-09
Onset:2021-04-09
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Cardiac arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-11
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: TENORMIN; CARDIOASPIRIN; AMLODIPINE; PERINDOPRIL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension arterial
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021435841

Write-up: severe asthenia and death for cardiac arrest; severe asthenia and death for cardiac arrest; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) -WEB, regulatory authority number IT-MINISAL02-715475. An 81-year-old male patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 09Apr2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. Medical history included hypertension. Concomitant medication(s) included atenolol (TENORMIN) taken for an unspecified indication, start and stop date were not reported; acetylsalicylic acid (CARDIOASPIRIN) taken for an unspecified indication, start and stop date were not reported; amlodipine (AMLODIPINE) taken for hypertension, start and stop date were not reported; perindopril (PERINDOPRIL) taken for hypertension, start and stop date were not reported. The day after the second dose of the Pfizer vaccine the patient complained of severe asthenia; 2 days after vaccination, due to the worsening of the symptom, Emergency medical service was called and soon confirmed his death. The patient received the second dose of Pfizer vaccine on 09Apr2021; the following day he complained of severe asthenia which worsened with the passing of the hours; Emergency medical service was called and the operators, arriving a few minutes later, note his death. The patient''s physician (reporter) carried out an inspection after death has already occurred and drawed up an anamnestic report of death due to cardiac arrest. The patient died on 11Apr2021. The autopsy was performed. Update on 15Apr: following an interview with the referring doctor, we learn that the patient had vaccinated at 6 pm on 09Apr2021; the Vaccination Center was contacted to trace the lot but they did not find the patient''s documentation. The reporting physician stated that he has not drawn up any clinical report nor deemed it appropriate to request an autopsy; he referred that he only sent the death notification after learning of the death at 10:59 on 11Apr2021. Reporter''s comment: 14Apr2021: I carried out an inspection at the home of my patient after death has already occurred; I can consider death to be related to cardiac arrest following a hypertensive crisis; for lot number I will try to contact the patient''s son (the partner of the patient is affected by Alzheimer''s and she could not collaborate) not knowing which is the Vaccinal Center where the patient had gone; I will try to pursue the anamnestic report as requested. Sender''s comment: CRFV request for clinical report with anamnestic connection and vaccine lot 13Apr2021: request to the reporting physician (GP) of n. lot of the vaccine and anamnestic clinical report drawn up on ascertaining the death.; Reporter''s Comments: 14Apr2021: I carried out an inspection at the home of my patient after death has already occurred; I can consider death to be related to cardiac arrest following a hypertensive crisis; for lot number I will try to contact the patient''s son (the partner of the patient is affected by Alzheimer''s and she could not collaborate) not knowing which is the Vaccinal Center where the patient had gone; I will try to pursue the anamnestic report as requested.; Reported Cause(s) of Death: asthenia; cardiac arrest


VAERS ID: 1260515 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-01
Onset:2021-04-10
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205-57-034 / 1 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Chest pain, Dyspnoea, Pulmonary embolism
SMQs:, Anaphylactic reaction (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-12
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ALENDRONATE SODIUM; COLECALCIFEROL; RAMIPRIL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Benign breast lump removal (followed by radiotherapy treatment); Breast neoplasm female; Chemotherapy; Hypertension (About 10 years ago); Mastectomy (Approximately 30 years ago right mastectomy followed by chemotherapy treatment); Radiotherapy
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021435980

Write-up: Saturday 10Apr and Sunday 11Apr dyspnea on the stairs. on day 12Apr at 5.00 right chest pain. The symptoms refer to possible pulmonary embolism.; Saturday 10Apr and Sunday 11Apr dyspnea on the stairs. on day 12Apr at 5.00 right chest pain. The symptoms refer to possible pulmonary embolism.; Saturday 10Apr and Sunday 11Apr dyspnea on the stairs. on day 12Apr at 5.00 right chest pain. The symptoms refer to possible pulmonary embolism.; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB IT-MINISAL02-715631. An 83-year-old female patient received first dose of BNT162B2 (COMIRNATY) (Batch/Lot Number: ET7205-57-034) via intramuscular at right arm (right shoulder) on 01Apr2021 as single dose for covid-19 immunisation. The patient medical history included approximately 30 years ago right mastectomy followed by chemotherapy treatment. About 10 years ago, mild hypertension was found. In 2018, removal of left breast growth followed by radiotherapy treatment. Concomitant medications included ramipril taken for hypertension; alendronate sodium; colecalciferol. The events were serious for fatal and described as Saturday 10Apr2021 and Sunday 11Apr2021 dyspnea on the stairs. On 12Apr2021 at 5:00 right chest pain. The symptoms referred to possible pulmonary embolism (10Apr2021). The patient died on 12Apr2021. The reported cause of death was dyspnoea, chest pain, pulmonary embolism. An autopsy was not performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Saturday 10Apr and Sunday 11Apr dyspnea on the stairs. on day 12Apr at 5.00 right chest pain. The symptoms refer to possible pulmonary embolism.; Saturday 10Apr and Sunday 11Apr dyspnea on the stairs. on day 12Apr at 5.00 right chest pain. The sympto


VAERS ID: 1260516 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-13
Onset:2021-04-14
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2246 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardiopulmonary failure, Myocardial ischaemia
SMQs:, Cardiac failure (narrow), Acute central respiratory depression (broad), Other ischaemic heart disease (narrow), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial flutter; Cardiomyopathy; Parkinson''s disease
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021441482

Write-up: acute cardiac ischaemia and acute cardiorespiratory failure; acute cardiac ischaemia and acute cardiorespiratory failure; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB IT-MINISAL02-715933. An 89-year-old male patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EW2246; Expiration Date: 31Jul2021) via intramuscular route of administration on 13Apr2021 at 09:00 as 0.3 mL, cyclic for covid-19 immunization. Medical history included Parkinson, cardiomyopathy and atrial flutter from Oct2020 to an unknown date. The patient''s concomitant medications were not reported. On 14Apr2021, the patient experienced acute cardiac ischaemia and acute cardiorespiratory failure. The patient died on an unspecified date.The cause of death was Acute heart ischemia and Cardio-respiratory failure. It was unknown if an autopsy was performed. It was stated that, Multi-pathological fragile patient, Parkinson''s, heart disease (atrial flutter in Oct2020), on 13APr2021 administration of Pfizer Comirnaty vaccine and today death from acute cardiac episode. The outcome of the event was fatal.; Reporter''s Comments: Multi-pathological fragile patient, Parkinson''s, heart disease (atrial flutter in Oct2020), on 13APr2021 administration of Pfizer Comirnaty vaccine. Today death from acute cardiac episode; Reported Cause(s) of Death: Acute heart ischemia; Cardio-respiratory failure


VAERS ID: 1260517 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-14
Onset:2021-04-15
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2246 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardio-respiratory arrest, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-15
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: SIRIO; FRIPASS; FINASTERIDE; AZILECT; SINEMET; MANTADAN; ONGENTYS; SILODYX
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arteriopathy (not walking); Parkinson''s disease (for about 20 years); Prostatic hypertrophy
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021435922

Write-up: sudden death; cardio-respiratory arrest; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number IT-MINISAL02-715977. An 82-year-old male patient received the second dose of BNT162B2 (COMIRNATY, lot number: EW2246), intramuscularly at left deltoid on 14Apr2021 10:30 at single dose for COVID-19 immunisation. Medical history included Parkinson''s disease for about 20 years, not walking, lower limb arterial disease, and prostatic hypertrophy. Concomitant medications included carbidopa/melevodopa (SIRIO), cilostazol (FRIPASS), finasteride, rasagiline mesylate (AZILECT 1 mg tablets), carbidopa/levodopa (SINEMET), amantadine hydrochloride (MANTADAN), opicapone (ONGENTYS 25 mg hard capsules), and silodosin (SILODYX). The patient experienced sudden death on 15Apr2021. Family members reported that upon awakening the patient was fine, the daughter saw him before going to work, the wife reported that she lifted him and took him to the kitchen, she went away to retrieve the dentures in the bathroom from which she heard a noise (breath) wheezing, on arriving in the kitchen she found her husband not breathing, alerted the emergency health service, the doctor found the patient in cardio-respiratory arrest. The patient''s family had expressed, in writing, that they did not want to proceed with the diagnostic check for further information on the causes of death. Autopsy was not performed. Outcome of the event was fatal. Follow-up attempts completed. No further information expected.; Reported Cause(s) of Death: cardio-respiratory arrest


VAERS ID: 1260523 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-24
Onset:2021-03-24
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET3620 / 1 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood pH, Blood potassium, Blood pressure measurement, Blood sodium, Body temperature, C-reactive protein, Chest X-ray, Dyspnoea, Haemoglobin, Heart rate, Oxygen saturation, Oxygen saturation decreased, PCO2, PO2, Pyrexia, Respiratory failure, SARS-CoV-2 test, Superinfection bacterial, White blood cell count
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Hypokalaemia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NEBIVOLOL; OLMESARTAN MEDOXOMIL/AMLODIPINE
Current Illness: Arterial hypertension; Idiopathic pulmonary fibrosis (on waiting list for lung transplant)
Preexisting Conditions: Medical History/Concurrent Conditions: Chronic respiratory failure (on waiting list for lung transplant)
Allergies:
Diagnostic Lab Data: Test Date: 20210327; Test Name: Blood pH; Result Unstructured Data: Test Result:7,33 iU; Comments: INTERNATIONAL UNIT(S)-(UNDER 100); Test Date: 20210327; Test Name: Blood pH; Test Result: 7.28 [iU]; Test Date: 20210327; Test Name: k; Result Unstructured Data: Test Result:4.8; Test Date: 20210327; Test Name: k; Result Unstructured Data: Test Result:4.6; Test Date: 20210327; Test Name: blood pressure; Result Unstructured Data: Test Result:123/92 mmHg; Test Date: 20210327; Test Name: blood pressure; Result Unstructured Data: Test Result:135/80 mmHg; Test Date: 20210327; Test Name: Na; Result Unstructured Data: Test Result:142; Test Date: 20210327; Test Name: Na; Result Unstructured Data: Test Result:143; Test Date: 20210324; Test Name: Body temperature; Result Unstructured Data: Test Result:38,7 Centigrade; Test Date: 20210327; Test Name: Body temperature; Result Unstructured Data: Test Result:36 Centigrade; Test Date: 20210324; Test Name: CXR; Result Unstructured Data: Test Result:unknown results; Test Date: 20210327; Test Name: CXR; Result Unstructured Data: Test Result:unknown results; Test Date: 20210327; Test Name: C-reactive protein; Test Result: 56 mg/dl; Test Date: 20210327; Test Name: Hb; Result Unstructured Data: Test Result:16.7; Test Date: 20210327; Test Name: Hb; Result Unstructured Data: Test Result:16; Test Date: 20210327; Test Name: heart rate; Result Unstructured Data: Test Result:123 bpm; Test Date: 20210327; Test Name: O2 saturation; Test Result: 56 %; Test Date: 20210327; Test Name: O2 saturation; Test Result: 76 %; Test Date: 20210327; Test Name: O2 saturation; Test Result: 82 %; Test Date: 20210327; Test Name: O2 saturation; Test Result: 93 %; Test Date: 20210327; Test Name: pCO2; Result Unstructured Data: Test Result:66; Test Date: 20210327; Test Name: pCO2; Result Unstructured Data: Test Result:77; Test Date: 20210327; Test Name: pO2; Result Unstructured Data: Test Result:32; Test Date: 20210327; Test Name: pO2; Result Unstructured Data: Test Result:51; Test Date: 20210327; Test Name: COVID-19 molecular test; Result Unstructured Data: Test Result:negative; Test Date: 20210327; Test Name: White blood cells; Result Unstructured Data: Test Result:23 x10 9/l; Test Date: 20210327; Test Name: Spo2; Test Result: 56 %; Test Date: 20210327; Test Name: Spo2; Test Result: 82 %
CDC Split Type: ITPFIZER INC2021441435

Write-up: severe desaturation; progressive worsening of respiratory failure; worsening dyspnoea; fever; probable bacterial superinfection on exacerbation of the underlying disease".; This is a spontaneous report from a contactable physician downloaded from regulatory authority-WEB, regulatory authority number IT-MINISAL02-716356. A 61-years-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscular, administered in Arm Right on 24Mar2021 12:27 (Batch/Lot Number: ET3620; Expiration Date: Jun2021) as 0.3 mL for covid-19 immunisation. Medical history included ongoing idiopathic pulmonary fibrosis on waiting list for lung transplant, ongoing hypertension, chronic respiratory failure from an unknown date and unknown if ongoing on waiting list for lung transplant. Concomitant medication''s included nebivolol, amlodipine besilate, olmesartan medoxomil for hypertension, start and stop date were not reported. On 24Mar2021 the patient experienced fever, severe desaturation, progressive worsening of respiratory failure and worsening dyspnoea. Laboratory tests on 24Mar2021 included body temperature: 38,7 centigrade, chest x-ray unknown results on 24Mar2021. Lab tests and procedures on 27Mar2021 which included blood ph: 7,33 iu on 27Mar2021 INTERNATIONAL UNIT(S)-(UNDER 100), blood ph: 7.28 iu, blood potassium: 4.8, blood potassium: 4.6, blood pressure measurement: 123/92 mmhg, blood pressure measurement: 135/80 mmhg, blood sodium: 142, blood sodium: 143, body temperature: 36 centigrade, chest x-ray: unknown results, c-reactive protein: 56 mg/dl, haemoglobin: 16.7, haemoglobin: 16, SARS CoV2 negative antigenic swab. Clinical course of events included: Patient suffering from Idiopathic Pulmonary Fibrosis since June 2018, not on antifibrotic therapy due to the severity of the disease, referred for evaluation for inclusion in the lung transplant list since June 2018. Since August 2018, complicated by respiratory failure. Comorbidities: arterial hypertension under treatment with olmesartan amlodipine and nebivolol. Proposed to the patient, as per ministerial instructions, anti SARS CoV 2 vaccination with Comirnaty vaccine, performed on 24Mar2021. A few hours after administration reported fever up to 38.7 C for which the patient took paracetamol 1 g with resolution. Progressively reported worsening of respiratory failure with the need to increase the oxygen requirement from 5 l min to 10 l min. On the morning of 27Mar2021 patient transported from staff of emergency number to the emergency room due to worsening dyspnea and severe desaturation. The following information can be learned from the emergency room report 27Mar2021 at 7 am. On arrival vital signs HR 123 bpm, SpO2 56 percent in BLB mask. Arterial blood gas analysis h 07.53: pH 7.33, pCO2 66, pO2 32, Hb 16.7, K 4.8, Na 142, Lac 2.4, Glu 188. Positioned non-invasive mechanical ventilation with FiO2 1.0, PEEP 10, PS 10, given morphine 10mg iv, SpO2 76 percent. Resuscitator consultation 27Mar2021, h 9.14 am soporous but awakened state, SpO2 82 percent in NIV in PSV 12, PEEP 12, FiO2 1, BP 135 80 mmHg, anuric, reduced PEEP to 5 cmH20, PSV at 10. Continued maximal medical therapy in consideration of end organ stage disease, in the absence of the possibility of currently performing Ultiva lung transplantation in ic at 1 ml hr to treat respiratory discomfort. Infectious disease consultancy, 27Mar2021, h. 14.38 Patient with idiopathic pulmonary fibrosis in home oxygen therapy with usual 93 percent SpO2. Previous repeated isolations of multisensitive P. aeruginosa are reported. Currently patient in severe clinical conditions, soporous but awakened, SpO2 82 percent in NIV in PSV 12, PEEP 5, FiO2 1, stable hemodynamics, anuric. At the exams, neutrophilic leukocytosis WBC 23,000, procalcitonin within the limits, CRP 56 mg dl. Infectious disease consultation h15.21 very serious clinical conditions. Apyretic, dyspnoic, although the current clinical picture is certainly not attributable to bacterial superinfection rather than to an exacerbation of the underlying disease, recommended therapy with meropenem 2 g every 8 hours iv ciprofloxacin 400 mg every 8 hours iv, Bactrim 4 ampoules every 6 ev. nEGA in progress of NIPPV h 8.29 with FiO2 1.0, PEEP 10, PS 10 pH 7.28, pCO2 77, pO2 51, Hb 16, K 4.6, Na 143, Glu 173, Lac 1.0, BE 10 Overall administered: Morphine 10mg iv, Prednisone 160mg, MgSO4 2 vials, Salbutamol 1vial.h 09.45 Patient in the Covid Red Room, maintains multi-parameter monitoring. Venous catheter positioned, 50cc anuric patient. Positioned 2 AVPs, hydration, ventilation via NIV. In progress Remifentanil 5mg at 1ml h in syringe pump. 15.30 very serious conditions persist, picture compatible with bacterial superinfection on exacerbation of the underlying disease at 18.00 confirmed death. Diagnosis of discharge: Died in the emergency room. COVID19 negative. Acute respiratory failure in idiopathic pulmonary fibrosis awaiting transplant with probable bacterial superinfection on exacerbation of the underlying disease. The patient died on an unspecified date. It was not reported if an autopsy was performed. Outcome of evens was fatal.


VAERS ID: 1260529 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-13
Onset:2021-04-14
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2246 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardio-respiratory arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-14
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021441445

Write-up: Cardio-respiratory arrest in patient with hypertensive heart disease and chronic renal insufficiency to which the first dose of anti SARS-COV-2 COMINARTY vaccine was administered on 13Apr2021; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, regulatory authority number IT-MINISAL02-716456. A 70-year-old male patient received the first dose of BNT162B2 (COMIRNATY), intramuscularly in left shoulder on 13Apr2021 10:18 am (Batch/Lot Number: EW2246; Expiration Date: 31Jul2021) as 30 ug, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 14Apr2021, Cardio-respiratory arrest in patient with hypertensive heart disease and chronic renal insufficiency to which the first dose of anti SARS-COV-2 COMINARTY vaccine was administered on 13Apr2021. The patient died on 14Apr2021. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: Cardio-respiratory arrest in patient with hypertensive heart disease and chronic renal insufficiency to which the first dose of anti SARS-COV-2 COMINARTY vaccine was administered on 13Apr2021


VAERS ID: 1260535 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-04-12
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-12
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Femur fracture
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021441472

Write-up: Deep vein thrombosis in the leg with death due to probable massive pulmonary embolism; Deep vein thrombosis in the leg with death due to probable massive pulmonary embolism; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number IT-MINISAL02-716464. A 82-year-old male patient received first dose of BNT162B2 (COMIRNATY, Solution for injection, Batch/Lot Number: ET7205), via an unspecified route of administration in right shoulder on an unspecified date at 17:01 PM as single dose for COVID-19 immunization. Patient''s medical history included femur fracture from 01Aug2019 to unknown if ongoing. The patient''s concomitant medications were not reported. The patient experienced embolism lung and DVT on 12Apr2021. The event described as deep vein thrombosis in the leg with death due to probable massive pulmonary embolism. The seriousness was fatal. The patient died on 12Apr2021. It was not reported if an autopsy was performed. The outcome of event was fatal.; Reported Cause(s) of Death: probable massive pulmonary embolism


VAERS ID: 1260547 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-08
Onset:2021-04-10
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2246 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal distension, Body temperature, Body temperature decreased, Cardio-respiratory arrest, Dyschezia, Dysuria, Malaise
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Gastrointestinal nonspecific dysfunction (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-10
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XOTERNA; SIMVASTATIN; CARDIOASPIRIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COPD (in oxygen treatment); Smoker; Tabaquism
Allergies:
Diagnostic Lab Data: Test Date: 20210410; Test Name: body temperature; Result Unstructured Data: Test Result:35.5 Centigrade
CDC Split Type: ITPFIZER INC2021441488

Write-up: body temperature of 35.5 ? C; CARDIO-RESPIRATORY ARREST; DIFFICULTY DEFECATING; MALAISE DAYS AFTER VACCINATION; DIFFICULTY URINATING; ABDOMINAL BLOATING; This is a spontaneous report from a contactable consumer downloaded from the Medicines Agency (MA) -WEB, regulatory authority number IT-MINISAL02-716697. A 75-year-old male patient received bnt162b2 (Pfizer vaccine), via an unspecified route of administration on 08Apr2021 (Lot Number: EW2246) as single dose for covid-19 immunisation. Medical history included Tabaquism, COPD (in oxygen treatment), smoker; all from unknown date and unknown if ongoing. Concomitant medications included glycopyrronium bromide, indacaterol maleate (XOTERNA); simvastatin; acetylsalicylic acid (CARDIOASPIRIN). The patient experienced abdominal bloating, difficulty urinating, difficulty defecating, malaise days after vaccination, cardio-respiratory arrest on 10Apr2021. The patient in the days following vaccination complained of abdominal swelling, difficulty in urinating (he urinated little) and defecating (he did not defecate) and a sense of general malaise. At 18.00 of 10Apr2021 measured a body temperature of 35.5 ? C at 19:00 lies down to rest, is found lifeless at about 21:30 by family members. The intervention of the first aid station ascertained the death for cardio-circulatory arrest. The outcome of the events was fatal. The patient died on 10Apr2021 due to events. No autopsy was performed. Sender comment: 16Apr2021 Pharmacovigilance manager, reporter informs that no autopsy examination will be performed. Asked the reporter for clinical documentation Pending.; Reported Cause(s) of Death: body temperature of 35.5 ? C; CARDIO-RESPIRATORY ARREST; DIFFICULTY DEFECATING; MALAISE DAYS AFTER VACCINATION; DIFFICULTY URINATING; ABDOMINAL BLOATING


VAERS ID: 1260554 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-24
Onset:2021-04-08
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET3620 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Coronavirus test, Multiple organ dysfunction syndrome, Septic shock, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Sepsis (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-12
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arthrosis multiple; Atrial fibrillation paroxysmal; Depressive symptom; Embolism pulmonary; Hyperthyroidism; Intestinal resection; Type 2 diabetes mellitus
Allergies:
Diagnostic Lab Data: Test Date: 20210408; Test Name: quick swab; Result Unstructured Data: Test Result:positive
CDC Split Type: ITPFIZER INC2021441421

Write-up: THE PATIENT RECEIVED SECOND VACCINE COVID PFIZER DATED 23Mar2021. ON APRIL 08TH, SHE WAS POSITIVE TO Nasopharyngeal TAMPON. On April 12, she was admitted for septic shock and multi-organ failure (MOF) that resulted in the death of the patient; THE PATIENT RECEIVED SECOND VACCINE COVID PFIZER DATED 23Mar2021. ON APRIL 08TH, SHE WAS POSITIVE TO Nasopharyngeal TAMPON. On April 12, she was admitted for septic shock and multi-organ failure (MOF) that resulted in the death of the patient; THE PATIENT RECEIVED SECOND VACCINE COVID PFIZER DATED 23Mar2021. ON APRIL 08TH, SHE WAS POSITIVE TO Nasopharyngeal TAMPON. On April 12, she was admitted for septic shock and multi-organ failure (MOF) that resulted in the death of the patient; THE PATIENT RECEIVED SECOND VACCINE COVID PFIZER DATED 23Mar2021. ON APRIL 08TH, SHE WAS POSITIVE TO Nasopharyngeal TAMPON. On April 12, she was admitted for septic shock and multi-organ failure (MOF) that resulted in the death of the patient; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) -WEB, regulatory authority number IT-MINISAL02-716828. An 86-years-old female patient received 2nd dose of BNT162B2 (Pfizer vaccine, Formulation: Solution for injection) intramuscular on 24Mar2021 (Batch/Lot Number: ET3620) as SINGLE DOSE for covid-19 immunisation. Medical history included pulmonary embolism, depressive symptom, intestinal, atrial fibrillation, hyperthyroidism, osteoarthritis, type 2 diabetes mellitus from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. On 08Apr2021, the patient experienced the vaccination failure, coronavirus infection, septic shock and multiple organ dysfunction syndrome and was positive to nasopharyngeal tampon. On 12 Apr 2021, she was admitted for septic shock and multi-organ failure (mof) that resulted in the death of the patient. Reporter comment: The death was related to multi-organ failure in the course of septic shock in covid-19 positive post-vaccination (16 days interval between second vaccination and positive swab and symptomatology). The action taken in response to the events for bnt162b2 was not applicable. Actions taken (Non-invasive ventilation with CPAP modality, empiric IV antibiotic therapy with ceftriaxone, meropenem and vancomycin, high-flow oxygen therapy, administration of vasoactive amines, EBPM at anticoagulant dosage, hydration and bicarbonate supplementation. Performance of hemocultures with positive finding for Staphylococcus Capitis). The patient died on 12Apr2021. It was not reported weather an autopsy was performed or not.; Reporter''s Comments: The death was related to multi-organ failure in the course of septic shock in covid-19 positive post-vaccination (16 days interval between second vaccination and positive swab and symptomatology).; Reported Cause(s) of Death: THE PATIENT RECEIVED SECOND VACCINE COVID PFIZER DATED 23Mar2021. ON APRIL 08TH, SHE WAS POSITIVE TO Nasopharyngeal TAMPON. On April 12, she was admitted for septic shock and multi-organ failure (MOF) that resulted in the death of the patient; THE PA


VAERS ID: 1260570 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-31
Onset:2021-04-10
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER9470 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Chest scan, Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-10
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: chest; Result Unstructured Data: Test Result:unknown results
CDC Split Type: ITPFIZER INC2021441475

Write-up: Death; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, regulatory authority number IT-MINISAL02-716938. A 48-year-old male patient received second dose bnt162b2 (COMIRNATY, Batch/Lot Number: ER9470), via an unspecified route of administration on 31Mar2021 at 09:47 as 0.3 mL cyclic for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced death on 10Apr2021. The event was reported as follows: Death, on which cause, an investigation by the judicial authority covered by confidentiality is underway, which occurred ten days after the administration of the 2nd dose of Pfizer vaccine. Performed in life, before death, Chest CT scan of which the outcome is unknown. The outcome of the event was fatal. Reporter''s comment: 1st dose of the Anti-Covid vaccination performed on 09Mar2021 with Pfizer vaccine - lot EP2166; 2nd dose with Pfizer Covid vaccine - lot ER9470 on 31Mar2021. No routine follow-up is possible for EV-WEB ICSRs. Follow-up should be performed according to GVP module VI only.; Reporter''s Comments: 1st dose of the Anti-Covid vaccination performed on 09Mar2021 with Pfizer vaccine - lot EP2166; 2nd dose with Pfizer Covid vaccine - lot ER9470 on 31Mar2021.; Reported Cause(s) of Death: death


Result pages: prev   1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1291&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166